Medivolve Inc
OTC:MEDVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medivolve Inc
Current Portion of Long-Term Debt
Medivolve Inc
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medivolve Inc
OTC:MEDVF
|
Current Portion of Long-Term Debt
CA$43.3k
|
CAGR 3-Years
-81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
Current Portion of Long-Term Debt
CA$87.6m
|
CAGR 3-Years
47%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
WELL Health Technologies Corp
TSX:WELL
|
Current Portion of Long-Term Debt
CA$109.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
dentalcorp Holdings Ltd
TSX:DNTL
|
Current Portion of Long-Term Debt
CA$29.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lithos Energy Ltd
CNSX:LITS
|
Current Portion of Long-Term Debt
CA$929.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healwell Al Inc
TSX:AIDX
|
Current Portion of Long-Term Debt
CA$26.4m
|
CAGR 3-Years
189%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Medivolve Inc
Glance View
Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.
See Also
What is Medivolve Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
43.3k
CAD
Based on the financial report for Dec 31, 2023, Medivolve Inc's Current Portion of Long-Term Debt amounts to 43.3k CAD.
What is Medivolve Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
-81%
Over the last year, the Current Portion of Long-Term Debt growth was -90%. The average annual Current Portion of Long-Term Debt growth rates for Medivolve Inc have been -81% over the past three years .
